(Z)-2-Chloro-N'-hydroxyacetimidamide

Catalog No.: 
ACFDST573
CAS No.: 
1403889-97-3
Molecular Formula: 
C2H5ClN2O
Molecular Weight: 
108.53
(Z)-2-Chloro-N'-hydroxyacetimidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$229.00InquiryInquiry
5g97%$1134.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-2-Chloro-N'-hydroxyacetimidamide
IUPAC Name(Z)-2-chloro-N'-hydroxyacetimidamide
MDL No.MFCD06673460
Molecular FormulaC2H5ClN2O
Molecular Weight108.53
SMILESN/C(CCl)=N\O
InChI KeyXCARGDPHZYJCMU-UHFFFAOYSA-N
Synonym2-chloro-N'-hydroxyacetimidamide;(Z)-2-Chloro-N'-hydroxyethanimidamide;Ethanimidamide, 2-chloro-N'-hydroxy-, (1Z)-
CAS No.1403889-97-3

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H312-H315-H318-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFDST573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDST573 route product structure diagram
    ACFDST5731403889-97-3
Inquiry

2. ACFDST573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDST573 route product structure diagram
    ACFDST5731403889-97-3
Inquiry

3. ACFDST573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFDST573 route product structure diagram
    ACFDST5731403889-97-3
Inquiry

Comments (0)